Aviva
ALAB icon

Aviva’s Astera Labs ALAB Stock Holding History

Aviva’s Portfolio ALAB Stock Details ALAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$10.2M Buy
93,372
+7,982
+9% +$1.14M 0.02% 529
2025
Q4 		$14.2M Buy
85,390
+83,028
+3,515% +$13.9M 0.02% 479
2025
Q3 		$462K Buy
+2,362
New +$388K ﹤0.01% 811

Other funds holding ALAB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Aviva's ALAB Position: Q1 2026 in Review

Aviva increased its Astera Labs (ALAB) stake by 9.3% in Q1 2026, buying an estimated $1.14M and bringing the position to 93,372 shares worth $10.2M. The position accounts for 0.02% of the portfolio, ranked #529.

Aviva first reported a position in ALAB in Q3 2025 and has held it in 3 quarters since. The position peaked at $14.2M in Q4 2025. 703 funds tracked by Wall St. Rank hold ALAB as of Q1 2026.

  • Aviva held 93,372 shares of Astera Labs worth $10.2M as of Q1 2026.
  • Aviva bought 7,982 Astera Labs shares in Q1 2026, an estimated $1.14M.
  • Astera Labs made up 0.02% of Aviva's portfolio in Q1 2026, its #529 holding.
  • Aviva first reported a position in Astera Labs in Q3 2025 and has held it in 3 quarters since.
  • Aviva's Astera Labs position peaked at $14.2M in Q4 2025.
  • 703 funds tracked by Wall St. Rank held Astera Labs as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.